213 related articles for article (PubMed ID: 35177989)
1. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.
Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H
Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989
[No Abstract] [Full Text] [Related]
2. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.
Abignano G; Blagojevic J; Bissell LA; Dumitru RB; Eng S; Allanore Y; Avouac J; Bosello S; Denton CP; Distler O; Ferraccioli G; Jordan S; Matucci-Cerinic M; Ong V; Messenger M; Hutchinson M; Buch MH; Emery P; Del Galdo F
Rheumatology (Oxford); 2019 Feb; 58(2):254-259. PubMed ID: 30239834
[TBL] [Abstract][Full Text] [Related]
3. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
4. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
5. The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis.
Abignano G; Cuomo G; Buch MH; Rosenberg WM; Valentini G; Emery P; Del Galdo F
Ann Rheum Dis; 2014 Feb; 73(2):420-7. PubMed ID: 23511226
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study.
Stojanovic M; Raskovic S; Milivojevic V; Miskovic R; Soldatovic I; Stankovic S; Rankovic I; Stankovic Stanojevic M; Dragasevic S; Krstic M; Diamantopoulos AP
J Cardiovasc Dev Dis; 2021 Dec; 8(12):. PubMed ID: 34940542
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
Puigvehí M; Hernández J; Broquetas T; Coll S; Garcia-Retortillo M; Cañete N; Giménez MD; Garcia M; Bory F; Salvadó M; Solà R; Carrión JA
PLoS One; 2016; 11(12):e0164883. PubMed ID: 27984583
[TBL] [Abstract][Full Text] [Related]
8. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
9. Enhanced liver fibrosis (ELF) score: Reference ranges, biological variation in healthy subjects, and analytical considerations.
Jabor A; Kubíček Z; Fraňková S; Šenkeříková R; Franeková J
Clin Chim Acta; 2018 Aug; 483():291-295. PubMed ID: 29772213
[TBL] [Abstract][Full Text] [Related]
10. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
[TBL] [Abstract][Full Text] [Related]
11. Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status.
Brusa S; Terracciano D; Bruzzese D; Fiorenza M; Stanziola L; Pinchera B; Valente V; Gentile I; Cittadini A; Mormile I; Mormile M; Portella G
Front Med (Lausanne); 2022; 9():1034288. PubMed ID: 36523781
[TBL] [Abstract][Full Text] [Related]
12. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.
Kawashiri SY; Origuchi T; Umeda M; Nishino A; Shimizu T; Fukui S; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Maeda T; Kawano M; Yamamoto M; Izumi Y; Kawakami A
Arthritis Res Ther; 2018 Dec; 20(1):277. PubMed ID: 30547825
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
[TBL] [Abstract][Full Text] [Related]
14. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
[TBL] [Abstract][Full Text] [Related]
15. Analytical performance of the Enhanced Liver Fibrosis (ELF) Test on the Atellica IM Analyzer.
Palladino A; Gee M; Shalhoub V; Kiaei D
Clin Chim Acta; 2023 Aug; 548():117461. PubMed ID: 37390944
[TBL] [Abstract][Full Text] [Related]
16. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
[TBL] [Abstract][Full Text] [Related]
17. Can the Enhanced Liver Fibrosis Score Be Used to Diagnose Children With Liver Fibrosis?
Thusing I; Antonsen S; Hoffmann-Petersen BS; Rasmussen HM; Wittenhagen P
J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):186-191. PubMed ID: 34620760
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
19. Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial.
Gawrieh S; Wilson LA; Yates KP; Cummings OW; Vilar-Gomez E; Ajmera V; Kowdley KV; Rosenberg WM; Tonascia J; Chalasani N
Hepatol Commun; 2021 May; 5(5):786-797. PubMed ID: 34027269
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan's Skin Score on Systemic Sclerosis.
Hikmat IH; Ramdhini SS; Soekersi H; Dewi S
Acta Med Indones; 2021 Jul; 53(3):254-260. PubMed ID: 34611063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
